FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Authorizes First Standalone Robotic Device for Blood Draws

FDA grants Vitestro a de novo authorization for Aletta, the first standalone robotic device designed to draw blood from a patients arm without hands-o...

latest-news-card-1
Human Drugs

Teva NDA for Tourette Syndrome Accepted for Review

FDA accepts for review a Teva Pharmaceuticals NDA for ecopipam, indicated for treating pediatric patients with Tourette syndrome.

latest-news-card-1
Human Drugs

CGMP Violations Found in Eugia Pharma Inspection

FDA warns Indias Eugia Pharma about CGMP violations at its drug manufacturing facility in Kolthur Village.

latest-news-card-1
FDA General

Trump Picks Health Policy Adviser Overton as FDA Commissioner Nominee

President Donald Trump selects White House health policy adviser Heidi Overton as his nominee to become FDA commissioner.

latest-news-card-1
Human Drugs

FDA Cites Neeyaan for Process Validation and Quality-System Failures

FDA cites Neeyaan LLC for multiple GMP deficiencies, including the firms failure to validate drug manufacturing processes, conduct cleaning validation...

latest-news-card-1
Medical Devices

How Will FDA Regulate Vision Language Models?

Mosaic Clinical Technologies petitions FDA to explain the regulatory principles it is applying to artificial intelligence vision language models.

Medical Devices

FDA Wants Feedback on Device GenAI Discussion Paper

FDA asks for stakeholder responses to six discussion questions in a paper on regulating generative AI-enabled medical devices.

latest-news-card-1
Human Drugs

4 API Manufacturing Violations at Chinas Tianjin Kilo

FDA warns Chinas Tianjin Kilo Pharmaceutical Sci-tech Co. about CGMP deviations the agency found in records it requested on the companys manufacturing...

latest-news-card-1
Human Drugs

Amylyx to File NDA Based on Positive Phase 3 Results for Avexitide

Amylyx Pharmaceuticals says it will file an NDA by the end of the year for its investigational drug avexitide.

latest-news-card-1
Human Drugs

McGuireWoods Narver Leaving Practice to Rejoin FDA

McGuireWoods partner Clint Narver announces his departure from the law practice to rejoin FDA as director of the Office of Compounding Quality and Com...